CERESPIR INCORPORATED

41 Madison Ave FL 31, New York City, New York, United States

Also known as:

cerespir

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

60.0%

Phase 2

40.0%

Trial Status Distribution

Completed

80.0%

Withdrawn

20.0%

Clinical Trials

Trials sponsored by this organization (5)

Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment

Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074

Phase 2

Completed

interventional

Mar 201196 participants

Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects

Phase 1

Completed

interventional

Feb 201112 participants

Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of CHF5074 in Healthy Young Male Subjects

Phase 1

Completed

interventional

Sep 201048 participants

Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects

Phase 1

Completed

interventional

Oct 200984 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations